Anawin Heavy Injection

Not for intrathecal use. Avoid use of solutions containing antimicrobial preservatives (i.e., multiple-dose vials) for epidural or caudal anesthesia. Three mL of Bupivacaine Hydrochloride and Epinephrine Injection without antimicrobial preservative (0.5% bupivacaine with 1:200,000 epinephrine) is recommended for use as a test dose prior to caudal and lumbar epidural blocks when clinical conditions permit.

Directions from the U.S. FDA-approved label for Bupivacaine — your doctor or pharmacist may advise differently.

Bupivacaine Hydrochloride Injection/Bupivacaine Hydrochloride and Epinephrine Injection is contraindicated in: obstetrical paracervical block anesthesia. Its use in this technique has resulted in fetal bradycardia and death. intravenous regional anesthesia (Bier Block). patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of Bupivacaine Hydrochloride Injection/Bupivacaine Hydrochloride and Epinephrine Injection. Obstetrical paracervical block anesthesia.

Excerpt from the U.S. FDA-approved label for Bupivacaine. Talk to a pharmacist or doctor before use.

Serious Neurologic Adverse Reactions with Epidural Administration Serious neurologic events, some resulting in death, have been reported with epidural injection of corticosteroids. Specific events reported include, but are not limited to, spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke. These serious neurologic events have been reported with and without use of fluoroscopy. The safety and effectiveness of epidural administration of corticosteroids have not been established, and corticosteroids are not approved for this use. General This product is not suitable for multi-dose use.

Warnings and precautions excerpt from the U.S. FDA-approved label for Bupivacaine — not a complete list. Talk to a pharmacist or doctor before use.

The following clinically significant adverse reactions have been reported and described in the Warnings and Precautions section of the labeling: Cardiac Arrest in Obstetrical Anesthesia Dose-Related Toxicity Methemoglobinemia Chondrolysis with Intra-Articular Infusion Severe, Persistent Hypertension, Cerebrovascular Accidents, and Bradycardia Due to Drug Interactions Cardiac Arrest with Intravenous Regional Anesthesia Use…

Excerpt from the U.S. FDA-approved label for Bupivacaine — not a complete list. Talk to a pharmacist or doctor about side effects.

10 brands · 5 makers in the NepalDoc catalog — see the full Bupivacaine guide →

Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F).

Storage information from the U.S. FDA-approved label for Bupivacaine.